Publication:
Fitness costs and the rapid spread of kelch13-C580Y substitutions conferring artemisinin resistance

dc.contributor.authorShalini Nairen_US
dc.contributor.authorXue Lien_US
dc.contributor.authorGrace A. Aryaen_US
dc.contributor.authorMarina McDew-Whiteen_US
dc.contributor.authorMarco Ferrarien_US
dc.contributor.authorFrançois Nostenen_US
dc.contributor.authorTim J.C. Andersonen_US
dc.contributor.otherUniversità degli Studi di Milanoen_US
dc.contributor.otherUniversity of Oxforden_US
dc.contributor.otherTexas Biomedical Research Instituteen_US
dc.contributor.otherMahidol Universityen_US
dc.date.accessioned2019-08-23T11:47:41Z
dc.date.available2019-08-23T11:47:41Z
dc.date.issued2018-09-01en_US
dc.description.abstractCopyright © 2018 Nair et al. Fitness costs are key determinants of whether drug resistance alleles establish and how fast they spread within populations. More than 125 different kelch13 alleles, each containing a different amino acid substitution, have arisen in Southeast Asian malaria parasite (Plasmodium falciparum) populations under artemisinin selection over the past 15 years in a dramatic example of a soft selective event. However, just one of these alleles (C580Y) is now outcompeting other alleles in multiple different countries and is spreading toward fixation. Here we examine the fitness consequences of C580Y, relative to another less successful kelch13 mutation (R561H), to try to explain the distinctive dynamics of C580Y. We hypothesized that C580Y will show lower fitness costs than other kelch13 substitutions in the absence of artemisinin treatment. We used CRISPR/Cas9 methods to introduce single mutations (C580Y or R561H) or synonymous control edits into a wild-type parasite isolated on the Thailand-Myanmar border, conducted replicated head-to-head competition assays, and determined the outcome of competition using deep sequencing of kelch13 amplicons. Contrary to our predictions, these experiments reveal that C580Y carries higher fitness costs (s [selection coefficient] 0.15 0.008 [1 standard error {SE}]) than R561H (s 0.084 0.005). Furthermore, R561H outcompetes C580Y in direct competition (s 0.065 0.004). We conclude that fitness costs of C580Y in isolation are unlikely to explain the rapid spread of this substitution.en_US
dc.identifier.citationAntimicrobial Agents and Chemotherapy. Vol.62, No.9 (2018)en_US
dc.identifier.doi10.1128/AAC.00605-18en_US
dc.identifier.issn10986596en_US
dc.identifier.issn00664804en_US
dc.identifier.other2-s2.0-85052196983en_US
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/20.500.14594/46403
dc.rightsMahidol Universityen_US
dc.rights.holderSCOPUSen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85052196983&origin=inwarden_US
dc.subjectMedicineen_US
dc.subjectPharmacology, Toxicology and Pharmaceuticsen_US
dc.titleFitness costs and the rapid spread of kelch13-C580Y substitutions conferring artemisinin resistanceen_US
dc.typeArticleen_US
dspace.entity.typePublication
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85052196983&origin=inwarden_US

Files

Collections